Anaptysbio (ANAB) Equity Ratio (2016 - 2025)
Historic Equity Ratio for Anaptysbio (ANAB) over the last 11 years, with Q3 2025 value amounting to 0.08.
- Anaptysbio's Equity Ratio fell 14872.26% to 0.08 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.08, marking a year-over-year decrease of 14872.26%. This contributed to the annual value of 0.15 for FY2024, which is 2479.01% down from last year.
- As of Q3 2025, Anaptysbio's Equity Ratio stood at 0.08, which was down 14872.26% from 0.13 recorded in Q2 2025.
- Anaptysbio's Equity Ratio's 5-year high stood at 0.96 during Q1 2021, with a 5-year trough of 0.13 in Q2 2025.
- Its 5-year average for Equity Ratio is 0.35, with a median of 0.29 in 2023.
- Its Equity Ratio has fluctuated over the past 5 years, first surged by 204.17% in 2021, then crashed by 67724.0% in 2025.
- Anaptysbio's Equity Ratio (Quarter) stood at 0.55 in 2021, then fell by 22.53% to 0.43 in 2022, then tumbled by 54.65% to 0.19 in 2023, then fell by 24.79% to 0.15 in 2024, then plummeted by 156.88% to 0.08 in 2025.
- Its Equity Ratio was 0.08 in Q3 2025, compared to 0.13 in Q2 2025 and 0.08 in Q1 2025.